Daniel R Passeri Cue Biopharma, Inc. (CUE) insider trading activity

Daniel R Passeri is CHIEF EXECUTIVE OFFICER of Cue Biopharma, Inc.. Currently has a direct ownership of 164,578 shares of CUE, which is worth approximately $172,806. The most recent transaction as insider was on Dec 16, 2024, when has been sold 30,000 shares (Common Stock) at a price of $1.03 per share, resulting in proceeds of $30,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 165K

22.29% 3M change

22.29% 12M change

Total Value Held $172,806

DANIEL R PASSERI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 16 2024	BUY Open market or private purchase	$30,900 $1.03 p/Share	30,000 Added 15.42%	164,578 Common Stock
Aug 14 2023	BUY Open market or private purchase	$8,580 $2.86 p/Share	3,000 Added 2.18%	134,578 Common Stock
Mar 31 2022	SELL Payment of exercise price or tax liability	$156,755 $4.88 p/Share	32,122 Reduced 18.49%	141,578 Common Stock
Mar 31 2022	SELL Bona fide gift	-	10,000 Reduced 7.06%	131,578 Common Stock
Mar 31 2022	BUY Exercise of conversion of derivative security	-	75,000 Added 30.16%	173,700 Common Stock
Sep 30 2021	SELL Payment of exercise price or tax liability	$461,534 $14.57 p/Share	31,677 Reduced 24.3%	98,700 Common Stock
Sep 30 2021	BUY Exercise of conversion of derivative security	-	75,000 Added 36.52%	130,377 Common Stock
Sep 24 2021	BUY Open market or private purchase	$50,048 $14.72 p/Share	3,400 Added 5.78%	55,377 Common Stock

DRP

Daniel R Passeri

CHIEF EXECUTIVE OFFICER

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CUE shares.

Notify only if

Value

Insider Trading

Get notified when an Cue Biopharma, Inc. insider buys or sells CUE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cue Biopharma, Inc.

Track Activities on CUE

Account